Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer(PROCLAIM) | completed | Phase 3 | 598 | Eli Lilly and CompanyINDUSTRY | 19 | Jun 28, 2016 | clinicaltrials |
| NCT00826449 | Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT01441752 | Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients | completed | Phase 3 | 349 | xulingOTHER | 1 | Jun 27, 2016 | clinicaltrials |
| NCT01788566 | A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer | completed | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 7 | Jun 27, 2016 | clinicaltrials |
| NCT01134016 | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects(Hocena) | completed | Phase 1 | 13 | Golden Biotechnology CorporationINDUSTRY | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01194453 | Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer(AP/GP) | completed | Phase 2 | 288 | Sun Yat-sen UniversityOTHER | 1 | Jun 16, 2016 | clinicaltrials |
| NCT00508625 | A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab | completed | Phase 2 | 213 | AmgenINDUSTRY | 0 | Jun 14, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT02040064 | Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients(GEFTREM) | completed | Phase 1 | 27 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT01666977 | Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | AmgenINDUSTRY | 6 | Jun 3, 2016 | clinicaltrials |
| NCT00259064 | Iressa v BSC (Best Supportive Care) in First Line NSCLC(INSTEP) | completed | Phase 2 / Phase 3 | 216 | AstraZenecaINDUSTRY | 5 | Jun 2, 2016 | clinicaltrials |
| NCT02109549 | Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.(Metformin) | completed | — | 70 | Maastricht Radiation OncologyOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT00933777 | SORAVE - Sorafenib and Everolimus in Solid Tumors(SORAVE) | completed | Phase 1 | 36 | University of CologneOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT00642473 | A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash(MATER) | completed | Phase 2 | 34 | Hoffmann-La RocheINDUSTRY | 1 | May 23, 2016 | clinicaltrials |
| NCT01047059 | Molecular Imaging With Erlotinib and Bevacizumab(MIMEB) | completed | Phase 2 | 40 | University of CologneOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT00651508 | Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1 | Bristol-Myers SquibbINDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT00518011 | A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. | completed | Phase 2 | 17 | Hoffmann-La RocheINDUSTRY | 1 | May 16, 2016 | clinicaltrials |
| NCT01291017 | Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. | completed | Phase 2 | 19 | University of FloridaOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT01042288 | Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC | completed | Phase 2 | 70 | SCRI Development Innovations, LLCOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01115790 | A Phase 1 Study in Participants With Advanced Cancer | completed | Phase 1 | 150 | Eli Lilly and CompanyINDUSTRY | 1 | May 10, 2016 | clinicaltrials |
| NCT00555256 | A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)(SU/Rapamycin) | completed | Phase 1 | 19 | Washington University School of MedicineOTHER | 1 | May 6, 2016 | clinicaltrials |
| NCT02728492 | Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy | completed | Phase 1 | 51 | NewVac LLCINDUSTRY | 1 | May 3, 2016 | clinicaltrials |
| NCT02148380 | Combination of Chemotherapy and Gefitinib as First-line Treatment | completed | N/A | 121 | Baohui HanOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT00257608 | A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) | completed | Phase 3 | 1,145 | Genentech, Inc.INDUSTRY | 17 | Apr 18, 2016 | clinicaltrials |
| NCT01792479 | A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 64 | BIND TherapeuticsINDUSTRY | 2 | Apr 15, 2016 | clinicaltrials |
| NCT00609804 | Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib | completed | Phase 2 | 53 | SCRI Development Innovations, LLCOTHER | 1 | Apr 8, 2016 | clinicaltrials |
| NCT00729742 | Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) | completed | Phase 1 | 49 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 4, 2016 | clinicaltrials |
| NCT02596958 | Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants | completed | — | 996 | Hoffmann-La RocheINDUSTRY | 1 | Apr 4, 2016 | clinicaltrials |
| NCT02720614 | Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer | completed | Phase 2 | 12 | LIN QIANGOTHER | 0 | Mar 28, 2016 | clinicaltrials |
| NCT00094835 | Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 51 | AmgenINDUSTRY | 0 | Mar 24, 2016 | clinicaltrials |
| NCT01941303 | Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease | completed | — | 34 | Maastricht Radiation OncologyOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02714335 | The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients | completed | — | 200 | Szu-Hua PanOTHER | 0 | Mar 22, 2016 | clinicaltrials |
| NCT01082549 | Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)(ECLIPSE) | completed | Phase 3 | 780 | SanofiINDUSTRY | 14 | Mar 17, 2016 | clinicaltrials |
| NCT00216125 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | completed | Phase 3 | 243 | Nasser Hanna, M.D.OTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT00888823 | Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 13 | AHS Cancer Control AlbertaOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT01297491 | Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer(BASALT-1) | completed | Phase 2 | 63 | Novartis PharmaceuticalsINDUSTRY | 18 | Mar 11, 2016 | clinicaltrials |
| NCT00198354 | Stage I/II NSCLC Perioperative Chemotherapy | completed | Phase 3 | 530 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00198432 | Chemoradiotherapy of NSCLC Stage IIIB | completed | Phase 2 | 130 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00683904 | Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 12 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00976456 | Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer(65plus) | completed | Phase 3 | 271 | PD Dr. med. Wolfgang SchuetteOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01522833 | Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer | completed | — | 27 | SCRI Development Innovations, LLCOTHER | 1 | Mar 7, 2016 | clinicaltrials |
| NCT01355484 | Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 321 | GTxINDUSTRY | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01124864 | A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. | completed | Phase 2 | 153 | Novartis PharmaceuticalsINDUSTRY | 10 | Mar 2, 2016 | clinicaltrials |
| NCT00129012 | Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01769066 | Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC | completed | Phase 2 / Phase 3 | 117 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01810367 | ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC | completed | Phase 2 | 84 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00940069 | TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer(TPEIAL) | completed | Phase 2 | 60 | Hunan Province Tumor HospitalOTHER | 1 | Feb 22, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Jun 28, 2016source: clinicaltrials